摘要
目的分析我国药学科普领域的研究热点及发展趋势,为药学科普实践和相关研究提供借鉴及可行性建议。方法检索CNKI、WanFang Data和VIP等中文文献数据库,搜集药学科普研究的相关文献,检索时限均为2014年1月—2024年5月,应用CiteSpace软件对纳入研究的作者、机构和文献关键词进行文献计量学分析。结果共纳入药学科普相关文献332篇,年发文量总体呈增长趋势。作者和机构均未形成紧密的合作网络,研究机构主要集中在医药高等院校和三级甲等医院。药学科普的主要研究热点是合理用药、问卷调查、儿童、临床药师、新型冠状病毒肺炎、药师、影响因素、微信公众平台、用药安全、中成药、用药咨询、用药风险、药事管理、知识-态度-行为、依从性等。目前仍在关注且突现强度较高的是用药咨询、用药风险、药物治疗管理、“互联网+”和知识-态度-行为。结论我国药学科普研究处于快速发展阶段,但药学工作者的科普积极性和科普技能仍有待提升。未来应加强学者间和机构间的交流合作,探索药学科普与多元化信息技术、新型医疗服务模式的有效融合路径,精准高效提高公众安全用药水平,助力健康中国战略的实施。
Objective To analyze the research hotspots and development trends in the field of pharmacy popularization in China,and to provide references and feasible suggestions for the practice of popular science in pharmacy and related research.Methods The CNKI,WanFang Data and VIP databases were searched to collect relevant references on popular science in pharmacy studies from January 2014 to February 2024,and the the authors,institutions and CiteSpace visualization software.Results 332 papers were included in the research,with an overall increasing trend in the number of publications.The cooperation networks of authors and research institutions were relatively scattered,research institutions were mainly concentrated in medical universities and tertiary hospitals.The main hotspot keywords were rational medication use,questionnaire survey,clinical pharmacist,COVID-19,pharmacist,influencing factors,WeChat platform,medication safety,children,medication consultation,medication risk,Chinese patent medicines,pharmaceutical management,knowledge-attitudepractice,compliance,et al.At present,there is still a high level of concern and emergence intensity of medication risk,knowledge-attitude-practice,medication therapy management and"Internet+".Conclusion The study of popularization of pharmacy science in China is in a stage of rapid development,but the enthusiasm and professional capabilities of pharmaceutical practitioners still need to be improved.In the future,it is necessary to actively promote deep exchanges and cooperations of scholars and institutions,explore the deep integration paths of popular science in pharmacy with information technology and new medical service models,and enhance the public's awareness and ability for safe medication through precise and efficient popularization strategies,thereby contributing to the in-depth implementation of the Healthy China strategy.
作者
都文文
马星海
李森
DU Wenwen;MA Xinghai;LI Sen(Drug Clinical Trial Institution,Jiaozuo People’s Hospital,Jiaozuo 454000,Henan Province,China;Department of Pharmacy,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China)
出处
《药物流行病学杂志》
CAS
2024年第8期919-928,共10页
Chinese Journal of Pharmacoepidemiology
基金
中国药学会2024年度科普研究重点项目(CMEI2024KPYJ001100)。